BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27118408)

  • 1. Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.
    Tremblay CS; Brown FC; Collett M; Saw J; Chiu SK; Sonderegger SE; Lucas SE; Alserihi R; Chau N; Toribio ML; McCormack MP; Chircop M; Robinson PJ; Jane SM; Curtis DJ
    Leukemia; 2016 Oct; 30(10):1993-2001. PubMed ID: 27118408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.
    Bitoun M; Durieux AC; Prudhon B; Bevilacqua JA; Herledan A; Sakanyan V; Urtizberea A; Cartier L; Romero NB; Guicheney P
    Hum Mutat; 2009 Oct; 30(10):1419-27. PubMed ID: 19623537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Dynamin 2 GTPase function results in microcytic anaemia.
    Brown FC; Collett M; Tremblay CS; Rank G; De Camilli P; Booth CJ; Bitoun M; Robinson PJ; Kile BT; Jane SM; Curtis DJ
    Br J Haematol; 2017 Aug; 178(4):616-628. PubMed ID: 28466468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamin 2 mutations in Charcot-Marie-Tooth neuropathy highlight the importance of clathrin-mediated endocytosis in myelination.
    Sidiropoulos PN; Miehe M; Bock T; Tinelli E; Oertli CI; Kuner R; Meijer D; Wollscheid B; Niemann A; Suter U
    Brain; 2012 May; 135(Pt 5):1395-411. PubMed ID: 22451505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into wild-type dynamin 2 and the consequences of DNM2 mutations from transgenic zebrafish.
    Zhao M; Smith L; Volpatti J; Fabian L; Dowling JJ
    Hum Mol Genet; 2019 Dec; 28(24):4186-4196. PubMed ID: 31691805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlative SICM-FCM reveals changes in morphology and kinetics of endocytic pits induced by disease-associated mutations in dynamin.
    Ali T; Bednarska J; Vassilopoulos S; Tran M; Diakonov IA; Ziyadeh-Isleem A; Guicheney P; Gorelik J; Korchev YE; Reilly MM; Bitoun M; Shevchuk A
    FASEB J; 2019 Jul; 33(7):8504-8518. PubMed ID: 31017801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis.
    Khan I; Gril B; Steeg PS
    Cancer Res; 2019 Sep; 79(18):4689-4702. PubMed ID: 31311812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
    Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
    Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle-specific function of the centronuclear myopathy and Charcot-Marie-Tooth neuropathy-associated dynamin 2 is required for proper lipid metabolism, mitochondria, muscle fibers, neuromuscular junctions and peripheral nerves.
    Tinelli E; Pereira JA; Suter U
    Hum Mol Genet; 2013 Nov; 22(21):4417-29. PubMed ID: 23813975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of Dynamin-2 (DNM2) Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
    Sobh M; Aref S; Al Agdar M; El Zafrany M; El-Sokkary AMA
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1257-1264. PubMed ID: 37116148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
    Kierdaszuk B; Berdynski M; Karolczak J; Redowicz MJ; Zekanowski C; Kaminska AM
    Neuromuscul Disord; 2013 Mar; 23(3):219-28. PubMed ID: 23374900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two dynamin-2 genes are required for normal zebrafish development.
    Gibbs EM; Davidson AE; Trickey-Glassman A; Backus C; Hong Y; Sakowski SA; Dowling JJ; Feldman EL
    PLoS One; 2013; 8(2):e55888. PubMed ID: 23418470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamin 2 regulation of integrin endocytosis, but not VEGF signaling, is crucial for developmental angiogenesis.
    Lee MY; Skoura A; Park EJ; Landskroner-Eiger S; Jozsef L; Luciano AK; Murata T; Pasula S; Dong Y; Bouaouina M; Calderwood DA; Ferguson SM; De Camilli P; Sessa WC
    Development; 2014 Apr; 141(7):1465-72. PubMed ID: 24598168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO2 and IL2RG synergize in thymocytes to mimic the evolution of SCID-X1 gene therapy-associated T-cell leukaemia.
    Ruggero K; Al-Assar O; Chambers JS; Codrington R; Brend T; Rabbitts TH
    Leukemia; 2016 Sep; 30(9):1959-62. PubMed ID: 27256700
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytoplasmic interaction of the tumour suppressor protein hSNF5 with dynamin-2 controls endocytosis.
    Alfonso-Pérez T; Domínguez-Sánchez MS; García-Domínguez M; Reyes JC
    Oncogene; 2014 Jun; 33(23):3064-74. PubMed ID: 23851497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamins in human diseases: differential requirement of dynamin activity in distinct tissues.
    Laiman J; Lin SS; Liu YW
    Curr Opin Cell Biol; 2023 Apr; 81():102174. PubMed ID: 37230036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of LMO2 causes aberrant human T-Cell development in vivo by three potentially distinct cellular mechanisms.
    Wiekmeijer AS; Pike-Overzet K; Brugman MH; van Eggermond MCJA; Cordes M; de Haas EFE; Li Y; Oole E; van IJcken WFJ; Egeler RM; Meijerink JP; Staal FJT
    Exp Hematol; 2016 Sep; 44(9):838-849.e9. PubMed ID: 27302866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia.
    Cleveland SM; Smith S; Tripathi R; Mathias EM; Goodings C; Elliott N; Peng D; El-Rifai W; Yi D; Chen X; Li L; Mullighan C; Downing JR; Love P; Davé UP
    Stem Cells; 2013 May; 31(5):882-94. PubMed ID: 23378057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A centronuclear myopathy--dynamin 2 mutation impairs autophagy in mice.
    Durieux AC; Vassilopoulos S; Lainé J; Fraysse B; Briñas L; Prudhon B; Castells J; Freyssenet D; Bonne G; Guicheney P; Bitoun M
    Traffic; 2012 Jun; 13(6):869-79. PubMed ID: 22369075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.